Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma

Published:2015-07-23 Issue:1 Volume:23 Page:67-77
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

De la Rosa Á J,Rodríguez-Hernández Á,González R,Romero-Brufau S,Navarro-Villarán E,Barrera-Pulido L,Pereira S,Marín L M,López-Bernal F,Álamo J M,Gómez-Bravo M A,Padillo F J,Muntané J

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201579.pdf

Reference43 articles.

1. Lancaster JR Jr . A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997; 1: 18–30.

2. Alderton WK, Cooper CE, Knowles RG . Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593–615.

3. Burke AJ, Sullivan FJ, Giles FJ, Glynn SA . The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013; 34: 503–512.

4. Muntane J, la Mata MD . Nitric oxide and cancer. World J Hepatol 2010; 2: 337–344.

5. McCarthy HO, Coulter JA, Robson T, Hirst DG . Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions. J Pharm Pharmacol 2008; 60: 999–1017.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma;Gene Therapy;2023-03-28

2. Impact of nitric oxide in liver cancer microenvironment;Nitric Oxide;2022-11

3. CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway;International Journal of Biological Sciences;2021

4. Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery;Journal of Controlled Release;2020-09

5. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma;Phytomedicine;2020-03